Artwork

เนื้อหาจัดทำโดย thefutureofdermatology เนื้อหาพอดแคสต์ทั้งหมด รวมถึงตอน กราฟิก และคำอธิบายพอดแคสต์ได้รับการอัปโหลดและจัดหาให้โดยตรงจาก thefutureofdermatology หรือพันธมิตรแพลตฟอร์มพอดแคสต์ของพวกเขา หากคุณเชื่อว่ามีบุคคลอื่นใช้งานที่มีลิขสิทธิ์ของคุณโดยไม่ได้รับอนุญาต คุณสามารถปฏิบัติตามขั้นตอนที่แสดงไว้ที่นี่ https://th.player.fm/legal
Player FM - แอป Podcast
ออฟไลน์ด้วยแอป Player FM !

Episode 44 - Understanding the Phenomenon of 'Ozempic Face' | The Future of Dermatology Podcast

38:12
 
แบ่งปัน
 

Manage episode 430457768 series 3512836
เนื้อหาจัดทำโดย thefutureofdermatology เนื้อหาพอดแคสต์ทั้งหมด รวมถึงตอน กราฟิก และคำอธิบายพอดแคสต์ได้รับการอัปโหลดและจัดหาให้โดยตรงจาก thefutureofdermatology หรือพันธมิตรแพลตฟอร์มพอดแคสต์ของพวกเขา หากคุณเชื่อว่ามีบุคคลอื่นใช้งานที่มีลิขสิทธิ์ของคุณโดยไม่ได้รับอนุญาต คุณสามารถปฏิบัติตามขั้นตอนที่แสดงไว้ที่นี่ https://th.player.fm/legal

Summary

Dr. Reed Berger, MD, PNS, an obesity medicine physician, discusses the use of GLP agonists and bariatric surgery in treating obesity. She explains the different types of GLP agonists and their approved uses for obesity and weight loss. Dr. Berger also discusses the efficacy and side effects of these medications, as well as the importance of protein in the diet for weight loss. She emphasizes the need for patients to receive proper nutrition and exercise guidance, and highlights the role of vitamins and supplements in supporting weight loss. In this conversation, Dr. Reed Berger discusses the use of GLP agonists in weight loss and the management of obesity. He explains that GLP agonists can be used after bariatric surgery to help patients maintain weight loss. The timing of starting GLP agonists after surgery depends on the individual patient. Dr. Berger also discusses the phenomenon of 'Ozempic face' and the potential causes behind it. He mentions that weight loss medications like phentermine and combination medications like Contrave can still be used in conjunction with GLP agonists. He also highlights the challenges of prior authorizations and medication shortages in the field of obesity medicine.

Takeaways

  • GLP agonists, such as Ozempic and Wegovy, are approved for weight loss and can help patients feel full and think about food less.
  • Protein is important for weight loss as it is thermogenic and helps maintain lean body mass.
  • Exercise is crucial for maintaining weight loss and increasing basal metabolic rate.
  • Vitamins and supplements, such as multivitamins, vitamin D, and vitamin B12, may be recommended to support weight loss.
  • Proper nutrition and exercise guidance are essential for patients starting GLP agonists or undergoing bariatric surgery.
  • GLP agonists can be used after bariatric surgery to help patients maintain weight loss.
  • The timing of starting GLP agonists after surgery depends on the individual patient.
  • Weight loss medications like phentermine and combination medications like Contrave can still be used in conjunction with GLP agonists.
  • Prior authorizations and medication shortages are challenges in the field of obesity medicine.
Chapters 00:00 - Introduction and Overview 02:15 - Dr. Berger's Clinic and Focus 04:29 - Benefits of Telemedicine for Weight Management 05:22 - Different GLP Agonists and Their Uses 09:08 - Efficacy and Mechanisms of GLP Agonists 10:18 - Effects on Hunger Sensation and Gastric Emptying 13:01 - Nutrition Recommendations for GLP Agonist Patients 15:14 - Incorporating Exercise into Weight Management 18:29 - Supplementation and Vitamins for Weight Loss Patients 19:53 - Using GLP Agonists After Bariatric Surgery 21:17 - The 'Ozempic Face' and Potential Mechanisms 24:26 - Treatment of the 'Ozempic Face' 26:50 - Challenges of Prior Authorizations and Medication Shortages 29:26 - Other Medications in Weight Management 35:26 - The Future of Obesity Medicine
  continue reading

64 ตอน

Artwork
iconแบ่งปัน
 
Manage episode 430457768 series 3512836
เนื้อหาจัดทำโดย thefutureofdermatology เนื้อหาพอดแคสต์ทั้งหมด รวมถึงตอน กราฟิก และคำอธิบายพอดแคสต์ได้รับการอัปโหลดและจัดหาให้โดยตรงจาก thefutureofdermatology หรือพันธมิตรแพลตฟอร์มพอดแคสต์ของพวกเขา หากคุณเชื่อว่ามีบุคคลอื่นใช้งานที่มีลิขสิทธิ์ของคุณโดยไม่ได้รับอนุญาต คุณสามารถปฏิบัติตามขั้นตอนที่แสดงไว้ที่นี่ https://th.player.fm/legal

Summary

Dr. Reed Berger, MD, PNS, an obesity medicine physician, discusses the use of GLP agonists and bariatric surgery in treating obesity. She explains the different types of GLP agonists and their approved uses for obesity and weight loss. Dr. Berger also discusses the efficacy and side effects of these medications, as well as the importance of protein in the diet for weight loss. She emphasizes the need for patients to receive proper nutrition and exercise guidance, and highlights the role of vitamins and supplements in supporting weight loss. In this conversation, Dr. Reed Berger discusses the use of GLP agonists in weight loss and the management of obesity. He explains that GLP agonists can be used after bariatric surgery to help patients maintain weight loss. The timing of starting GLP agonists after surgery depends on the individual patient. Dr. Berger also discusses the phenomenon of 'Ozempic face' and the potential causes behind it. He mentions that weight loss medications like phentermine and combination medications like Contrave can still be used in conjunction with GLP agonists. He also highlights the challenges of prior authorizations and medication shortages in the field of obesity medicine.

Takeaways

  • GLP agonists, such as Ozempic and Wegovy, are approved for weight loss and can help patients feel full and think about food less.
  • Protein is important for weight loss as it is thermogenic and helps maintain lean body mass.
  • Exercise is crucial for maintaining weight loss and increasing basal metabolic rate.
  • Vitamins and supplements, such as multivitamins, vitamin D, and vitamin B12, may be recommended to support weight loss.
  • Proper nutrition and exercise guidance are essential for patients starting GLP agonists or undergoing bariatric surgery.
  • GLP agonists can be used after bariatric surgery to help patients maintain weight loss.
  • The timing of starting GLP agonists after surgery depends on the individual patient.
  • Weight loss medications like phentermine and combination medications like Contrave can still be used in conjunction with GLP agonists.
  • Prior authorizations and medication shortages are challenges in the field of obesity medicine.
Chapters 00:00 - Introduction and Overview 02:15 - Dr. Berger's Clinic and Focus 04:29 - Benefits of Telemedicine for Weight Management 05:22 - Different GLP Agonists and Their Uses 09:08 - Efficacy and Mechanisms of GLP Agonists 10:18 - Effects on Hunger Sensation and Gastric Emptying 13:01 - Nutrition Recommendations for GLP Agonist Patients 15:14 - Incorporating Exercise into Weight Management 18:29 - Supplementation and Vitamins for Weight Loss Patients 19:53 - Using GLP Agonists After Bariatric Surgery 21:17 - The 'Ozempic Face' and Potential Mechanisms 24:26 - Treatment of the 'Ozempic Face' 26:50 - Challenges of Prior Authorizations and Medication Shortages 29:26 - Other Medications in Weight Management 35:26 - The Future of Obesity Medicine
  continue reading

64 ตอน

Todos os episódios

×
 
Loading …

ขอต้อนรับสู่ Player FM!

Player FM กำลังหาเว็บ

 

คู่มืออ้างอิงด่วน